Abstract
Background and aims: To review current practice in management of bronchiolitis and assess compliance with evidence based national guidelines. Methods: Results: Total: 75 patients. There were 39 males & 26 females. Of these 42 were < 6 months and 33 were >6 months. All our patients had SaO2 measured on admission. Blood gas was done only in 6/75 (8 %) due to worsening respiratory distress and increase in oxygen requirements. CXR was done in 12 /75 for atypical chest sign or worsening respiratory distress. NPA was done for inpatients 25/33 of which 13 were positive. None received Ribavarine. 7/75 (9.3%) received Antibiotics- These children were unwell or had worsening respiratory signs, high temperature or non Blanching spots. Salbutamol was given in 9/75 (12%). Nebulised ipratropium was given in 6/75 (8%).2 patients required CPAP support.1 patient with severe distress & recurrent apnoea was transferred to a tertiary PICU. On discharge all patients had saturations above 94% and oral intake more than 75% of normal. Conclusions: A very safe and evidence based practice is being followed that ensures that children who are seriously unwell are picked up and receive specialist care immediately. Reduction of unnecessary investigations and inappropriate treatment has ensured appropriate use of resources.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
